Importantly, only 52% of the grafted Pgp+ or Pgp- tumors developed into detectable tumors in the DOX-CSA-UIC2 treated animals (see Fig. 4B), and 20% of the animals remained completely tumor-free. This evidence concerns the gene PGP and neoplasm.